Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation-Reference-Cited by-同舟云学术

Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation

Published:2012-05-27 Issue:10 Volume:93 Page:1024-1030
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Oshita Akihiko,Tashiro Hirotaka,Amano Hironobu,Kobayashi Tsuyoshi,Onoe Takashi,Ide Kentaro,Takaki Shintaro,Takahashi Shoichi,Arihiro Koji,Chayama Kazuaki,Ohdan Hideki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference37 articles.

1. . Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.;Botha;Liver Int,2007

2. . Primary nonfunction of hepatic allografts with preexisting fatty infiltration.;Todo;Transplantation,1989

3. . The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation.;DAlessandro;Transplantation,1991

4. . Risk factors for primary dysfunction after liver transplantationA multivariate analysis.;Ploeg;Transplantation,1993

5. . Use of fatty donor liver is associated with diminished early patient and graft survival.;Marsman;Transplantation,1996

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconsiderations for the liver donation from a living donor: addressing hepatic steatosis with weight loss preconditioning;Hepatology International;2024-07-08

2. Is preoperative weight reduction of living-donor liver transplant recipients and donors harmful to postoperative outcomes?;Journal of Gastrointestinal Surgery;2024-07

3. Better liver transplant outcomes by donor interventions?;Current Opinion in Organ Transplantation;2024-05-24

4. Deceased by Brain Death Liver Transplant vs. Living Donor Transplant/Putting Deceased Donor on Pump;Liver Transplantation - Challenges and Opportunities;2024-04-05

5. Management of Steatosis in Living Donors: Where Do We Stand?;OBM Transplantation;2024-04-01